Back to Search
JOSHUA VEATCH, M.D., PH.D.
M.D., PH.D.
Hematology & Oncology Physician
NPI: 1407173826IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
60164370(WA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE
Class of 2010
Research & Publications (8)
Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect.
PMID 19563757·Cell·2009
8-other
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
PMID 19171714·J Clin Oncol·2009
3-trial
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
PMID 17369569·J Clin Oncol·2007
3-trial
Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
PMID 17102115·Ann N Y Acad Sci·2006
3-trial
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
PMID 16421427·J Clin Oncol·2006
3-trial
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma.
PMID 15197208·J Clin Oncol·2004
3-trial
Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome ends.
PMID 12975323·Genes Dev·2003
8-other
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
PMID 11696644·J Nucl Med·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1100 FAIRVIEW AVE N # D5-100
SEATTLE, WA 98109 - Phone
- (206) 618-5181
Quick Facts
- NPI
- 1407173826
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 16
- Publications
- 8
Are you this provider?
Claim Your Profile